Submit Deal

GILEAD SCIENCES

Summary

Gilead Sciences is an American biopharmaceutical company headquartered in Foster City, California.

Deals Overview

Total Deals24

Valued Deals21

Total Value£ 37.76 B

Avg. Deal Size£ 1.80 B

Market Context

Subsidiaries

GILEAD SCIENCES (KITE PRODUCTION FACILITY AND ASSETS)

1 transaction

Senior Management

Daniel O'Day
Chairman and CEO
Andrew Dickinson
CFO
Johanna Mercier
Chief Commercial Officer

Sort

28 Aug 2017|United States|Biotechnology

Target: KITE PHARMA INC

Bidder: GILEAD SCIENCES

10 Service Providers

5 Target | 5 Bidder

24 Dealmakers

9 Target | 15 Bidder

£ 9.30 B

Value

06 May 2019|United States|Biotechnology

Target: GOLDFINCH BIO

Bidder: GILEAD SCIENCES

3 Service Providers

1 Target | 2 Bidder

6 Dealmakers

1 Target | 5 Bidder

£ 83 M

Value

14 Jul 2019|Belgium|Biotechnology

Target: GALAPAGOS NV

Bidder: GILEAD SCIENCES

15 Service Providers

7 Target | 8 Bidder

36 Dealmakers

24 Target | 12 Bidder

£ 849 M

Value

02 Mar 2020|United States|Biotechnology

Target: FORTY SEVEN

Bidder: GILEAD SCIENCES

10 Service Providers

6 Target | 4 Bidder

48 Dealmakers

33 Target | 15 Bidder

£ 3.82 B

Value

27 May 2020|United States|Biotechnology

Target: ARCUS BIOSCIENCES

Bidder: GILEAD SCIENCES

9 Service Providers

3 Target | 6 Bidder

8 Dealmakers

3 Target | 5 Bidder

£ 162 M

Value

23 Jun 2020|United States|Health Care Services

Target: PIONYR IMMUNOTHERAPEUTICS INC

Bidder: GILEAD SCIENCES

7 Service Providers

4 Target | 3 Bidder

24 Dealmakers

6 Target | 19 Bidder

£ 221 M

Value

21 Jul 2020|United States|Medical Services

Target: TIZONA THERAPEUTICS

Bidder: GILEAD SCIENCES

6 Service Providers

3 Target | 3 Bidder

43 Dealmakers

23 Target | 20 Bidder

£ 235 M

Value

13 Sep 2020|United States|Pharmaceuticals

Target: IMMUNOMEDICS

Bidder: GILEAD SCIENCES

15 Service Providers

7 Target | 8 Bidder

50 Dealmakers

24 Target | 26 Bidder

£ 16.41 B

Value

10 Dec 2020|Germany|Biotechnology

Target: MYR GMBH

Bidder: GILEAD SCIENCES

10 Service Providers

3 Target | 5 Bidder | 2 Vendor

26 Dealmakers

18 Target | 3 Bidder | 4 Vendor

£ 1.31 B

Value

17 Mar 2021|United Kingdom|Biotechnology

Target: VACCITECH

Bidder: GILEAD SCIENCES

8 Service Providers

1 Target | 7 Bidder

22 Dealmakers

1 Target | 21 Bidder

£ 121 M

Value

14 Apr 2021|United States|Biotechnology

Target: TANGO THERAPEUTICS

Bidder: CORMORANT ASSET MANAGEMENT

29 Service Providers

5 Target | 24 Bidder

32 Dealmakers

15 Target | 19 Bidder

£ 257 M

Value

29 Jun 2021|United States|Biotechnology

Target: PARDES BIOSCIENCES

Bidder: ECOR1 CAPITAL

17 Service Providers

4 Target | 13 Bidder

37 Dealmakers

9 Target | 29 Bidder

£ 199 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy